125 related articles for article (PubMed ID: 7955454)
1. Increased insulin sensitivity in patients with aldosterone producing adenoma.
Ishimori M; Takeda N; Okumura S; Murai T; Inouye H; Yasuda K
Clin Endocrinol (Oxf); 1994 Oct; 41(4):433-8. PubMed ID: 7955454
[TBL] [Abstract][Full Text] [Related]
2. Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone-producing adenoma and idiopathic hyperaldosteronism.
Okazaki-Hada M; Moriya A; Nagao M; Oikawa S; Fukuda I; Sugihara H
J Diabetes Investig; 2020 Nov; 11(6):1511-1519. PubMed ID: 32470155
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a test using saralasin to differentiate primary aldosteronism due to an aldosterone-producing adenoma from idiopathic hyperaldosteronism.
Brown RD; Kem DC; Hogan MJ; Hegstad RL
Metabolism; 1984 Aug; 33(8):734-8. PubMed ID: 6748946
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
5. A possible association between primary aldosteronism and a lower beta-cell function.
Mosso LM; Carvajal CA; Maiz A; Ortiz EH; Castillo CR; Artigas RA; Fardella CE
J Hypertens; 2007 Oct; 25(10):2125-30. PubMed ID: 17885557
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone excess may inhibit insulin secretion: A comparative study on glucose metabolism pre- and post-adrenalectomy in patients with primary aldosteronism.
Tsurutani Y; Sugisawa C; Ishida A; Inoue K; Saito J; Omura M; Nagasaka S; Nishikawa T
Endocr J; 2017 Mar; 64(3):339-346. PubMed ID: 28111382
[TBL] [Abstract][Full Text] [Related]
7. Insulin action in primary hyperaldosteronism before and after surgical or pharmacological treatment.
Sindelka G; Widimský J; Haas T; Prázný M; Hilgertová J; Skrha J
Exp Clin Endocrinol Diabetes; 2000; 108(1):21-5. PubMed ID: 10768828
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone excess impairs first phase insulin secretion in primary aldosteronism.
Fischer E; Adolf C; Pallauf A; Then C; Bidlingmaier M; Beuschlein F; Seissler J; Reincke M
J Clin Endocrinol Metab; 2013 Jun; 98(6):2513-20. PubMed ID: 23539730
[TBL] [Abstract][Full Text] [Related]
9. Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma.
Komada H; Hirota Y; So A; Nakamura T; Okuno Y; Fukuoka H; Iguchi G; Takahashi Y; Sakaguchi K; Ogawa W
Diabetes Metab; 2020 Jun; 46(3):236-242. PubMed ID: 31676325
[TBL] [Abstract][Full Text] [Related]
10. Activation of aldosterone secretion in primary aldosteronism.
Spark RF; Dale SL; Kahn PC; Melby JC
J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
[TBL] [Abstract][Full Text] [Related]
11. Nondiabetic patients with either subclinical Cushing's or nonfunctional adrenal incidentalomas have lower insulin sensitivity than healthy controls: clinical implications.
Ivović M; Marina LV; Vujović S; Tančić-Gajić M; Stojanović M; Radonjić NV; Gajić M; Soldatović I; Micić D
Metabolism; 2013 Jun; 62(6):786-92. PubMed ID: 23332445
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas: a cause-effect relationship?
Peppa M; Boutati E; Koliaki C; Papaefstathiou N; Garoflos E; Economopoulos T; Hadjidakis D; Raptis SA
Metabolism; 2010 Oct; 59(10):1435-41. PubMed ID: 20153874
[TBL] [Abstract][Full Text] [Related]
13. Insulin sensitivity in patients with primary aldosteronism: a follow-up study.
Catena C; Lapenna R; Baroselli S; Nadalini E; Colussi G; Novello M; Favret G; Melis A; Cavarape A; Sechi LA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3457-63. PubMed ID: 16822818
[TBL] [Abstract][Full Text] [Related]
14. Aldosterone-producing-adenoma (A-P-A): effect of pregnancy.
Gordon RD; Tunny TJ
Clin Exp Hypertens A; 1982; 4(9-10):1685-93. PubMed ID: 6754149
[TBL] [Abstract][Full Text] [Related]
15. Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load.
Sasaki Y; Abe Y; Takeda H; Nishise S; Yaoita T; Yagi M; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kawata S; Ueno Y
Digestion; 2018; 97(4):324-332. PubMed ID: 29539609
[TBL] [Abstract][Full Text] [Related]
16. The effect of adrenal surgery on plasma atrial natriuretic factor and sodium escape phenomenon in patients with primary aldosteronism.
Nakada T; Furuta H; Katayama T; Sumiya H; Shimazaki J
J Urol; 1989 Jul; 142(1):13-8. PubMed ID: 2525199
[TBL] [Abstract][Full Text] [Related]
17. Effect of standard oral glucose loading on aldosterone secretion in primary hyperaldosteronism.
Beretta-Piccoli C; Weidmann P; Brown JJ; Fraser R; Lever AF; Marone C; Robertson JI
Acta Endocrinol (Copenh); 1982 Sep; 101(1):66-71. PubMed ID: 6751010
[TBL] [Abstract][Full Text] [Related]
18. Study of glucose tolerance in consecutive patients harbouring incidental adrenal tumours. Study Group of Incidental Adrenal Adenoma.
Fernández-Real JM; Engel WR; Simó R; Salinas I; Webb SM
Clin Endocrinol (Oxf); 1998 Jul; 49(1):53-61. PubMed ID: 9797847
[TBL] [Abstract][Full Text] [Related]
19. Primary aldosteronism with normal aldosterone levels in blood and urine.
Nomura K; Han DC; Jibiki K; Demura H; Tsushima T; Shizume K
Acta Endocrinol (Copenh); 1985 Dec; 110(4):522-5. PubMed ID: 4090913
[TBL] [Abstract][Full Text] [Related]
20. The plasma aldosterone response to angiotensin II infusion in aldosterone-producing adenoma and idiopathic hyperaldosteronism.
Wisgerhof M; Brown RD; Hogan MJ; Carpenter PC; Edis AJ
J Clin Endocrinol Metab; 1981 Feb; 52(2):195-8. PubMed ID: 7462385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
